A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2004
12/15/2004	EP1485121A2 Activated protein c formulations
12/15/2004	EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
12/15/2004	EP1485111A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
12/15/2004	EP1485110A1 Use of sulfoalkyl ether cyclodextrin as a preservative
12/15/2004	EP1485098A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine in nanoparticulate form
12/15/2004	EP1485094A1 FORM OF PRESENTATION FOR 3- (2-{ 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO -METHYL}-1-METHYL-1iH /i -BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO PROPIONIC ACID ETHYL ESTER TO BE ADMINISTERED ORALLY
12/15/2004	EP1485081A1 Ibuprofen solution for hard shell capsules
12/15/2004	EP1485080A1 Use of adapalene for the treatment of dermatological disorders
12/15/2004	EP1485076A1 Therapeutic methods for acute myeloid leukemia
12/15/2004	EP1485073A2 Method for administration of growth hormone via pulmonary delivery
12/15/2004	EP1485072A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
12/15/2004	EP1485071A2 Compressed tablets comprising microcapsules with modified release
12/15/2004	EP1485070A1 Pharmaceutical microparticles
12/15/2004	EP1485068A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
12/15/2004	EP1485066A1 Composition having gelling properties for the prolonged delivery of bioactive substances
12/15/2004	EP1485059A1 Topical dapsone for the treatment of acne
12/15/2004	EP1485050A2 A substance with sedative effect
12/15/2004	EP1335705B1 Preparation of drug particles using evaporation precipitation into aqueous solutions
12/15/2004	EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients
12/15/2004	EP1278780B1 Esterified polysaccharide products, compositions containing beta-lactone ring opened ketene dimer products and process of making the same
12/15/2004	EP1221964A4 Antigenic modification of polypeptides
12/15/2004	EP1221937B1 Hybrid matrices and hybrid matrix mixtures
12/15/2004	EP1115295A4 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
12/15/2004	EP1104287A4 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
12/15/2004	EP1047415B1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
12/15/2004	EP1030547B1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
12/15/2004	EP1028752B1 Platelet substitutes and conjugation methods suitable for their preparation
12/15/2004	EP1017283B1 Polynucleotide vaccine formulations
12/15/2004	EP1015022B1 New improved formulation for treatment of thromboembolism
12/15/2004	EP0969816B1 Preparation of powder agglomerates
12/15/2004	EP0929270B1 Oral peptide pharmaceutical products
12/15/2004	EP0869816B1 Dry compositions comprising hydrophobic stabilizers
12/15/2004	CN1555400A Polymeric hydrogel
12/15/2004	CN1555393A Keratin-based products and methods for their production
12/15/2004	CN1555385A Ligands to enhance cellular uptake of biomolecules
12/15/2004	CN1555269A Exothermic formulations for the treatment of ectoparasites
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555267A Method of treating middle ear infections
12/15/2004	CN1555265A Medical preparation for injection
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1555263A Compositions for treatment of common cold
12/15/2004	CN1555257A Ascites preventives for poultry
12/15/2004	CN1555256A Pharmaceutical formulation comprising a proton pump inhibitor and antacids
12/15/2004	CN1555253A Oily composition of taxol,preparation for chemical therapeutic embolism and their producing method
12/15/2004	CN1555252A Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
12/15/2004	CN1554446A Carrier transferred adjuvant antigen and its preparing method
12/15/2004	CN1554431A Restoring consciousness freezo-dried powder injection for injection and its preparing method
12/15/2004	CN1554349A Dry mix formulation for bisphosphonic acids
12/15/2004	CN1554336A Process for preparing water soluble arteannuin preparation
12/15/2004	CN1554330A Konjaku gluocomannan-calcium alginate microball for carrying medicine and preparing method
12/15/2004	CN1554329A Slow-releasing microball with nimoldipine and its preparing method
12/15/2004	CN1554328A Microball preparation for intestine orient releasing medicne and its preparing method
12/15/2004	CN1180079C Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179748C Stabilized pharmaceutical composition in lyophilized form
12/15/2004	CN1179721C Resin type ointment and its prepn
12/15/2004	CN1179720C Instant granules and process for their formulation
12/14/2004	US6831158 Granulocyte colony stimulating factor (g-csf) activity; polypeptide with an introduced and removed lysine residue conjugated to polyethylene glycol moieties; treatment of neutropenia or leukopenia
12/14/2004	US6831150 Combining an aldehyde or ketone, base, the glycopeptide, acidifying the reaction mixture and combining with a reducing agent to alkylate the glycopeptide at the saccharide amine; glycopeptide antibiotics
12/14/2004	US6831103 Composition comprising theanine
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830755 Method for relaxing human beings using personal care compositions
12/14/2004	US6830747 Copolymer (e.g., polylactone) capped at one end and linked at the other to a polyfunctional polymer segment (e.g., polyacrylic acid) reacted with an aminoxyl-containing radical or other drug molecule residue
12/14/2004	US6830745 Compositions for treating biofilm
12/14/2004	US6830744 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/14/2004	CA2286092C Sustained-release alginate gels
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004	CA2166109C Compositions for inhalation
12/14/2004	CA2154170C Cyclic imide thione activated polyalkylene oxides
12/09/2004	WO2004106511A1 OLIGO DOUBLE-STRANDED RNA INHIBITING THE EXPRESSION OF Bcl-2 AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/09/2004	WO2004106416A1 Cellulose powder
12/09/2004	WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	WO2004106359A2 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/09/2004	WO2004105824A1 A bioabsorbable delivery system
12/09/2004	WO2004105800A2 Complexing of medicinal substances with high-molecular strength
12/09/2004	WO2004105747A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex
12/09/2004	WO2004105745A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant
12/09/2004	WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	WO2004105730A1 Low sodium solution
12/09/2004	WO2004105729A2 Transdermal vaccine delivery device having coated microprotrusions
12/09/2004	WO2004105702A2 Foamable pharmaceutical compositions and methods for treating a disorder
12/09/2004	WO2004105694A2 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
12/09/2004	WO2004105686A2 Novel topical steroid cream formulations
12/09/2004	WO2004105492A1 Aqueous compositions for disinfection and/or sterilization
12/09/2004	WO2004089422A3 Methods of treating and monitoring systemic lupus erythematosus in individuals
12/09/2004	WO2004089339A3 Lipid particles having asymmetric lipid coating and method of preparing same
12/09/2004	WO2004084900A8 Topical formulation and use of buspirone
12/09/2004	WO2004082564A3 Coated enzyme granules
12/09/2004	WO2004066925B1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
12/09/2004	WO2004062628A3 Gilsonite derived pharmaceutical delivery compositions and methods
12/09/2004	WO2004060262A3 Modulators of notch signalling for use in immunotherpapy
12/09/2004	WO2004037983A3 Caged ligands and uses thereof
12/09/2004	WO2004032863A3 Oral formulations for proteins and polypeptides
12/09/2004	WO2004032829A3 Immunostimulatory compositions and methods of stimulating an immune response
12/09/2004	WO2004024168A8 Composition and method for use in intestinal cleansing procedures
12/09/2004	WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/09/2004	WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy
12/09/2004	WO2003101422A3 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents

1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 1712